Better with age: the silver opportunity

Download the article to read all the content on which this summary is based.

As human life expectancy steadily increases, governments are faced with the responsibility of providing health and social care to a population that has a greater proportion of elderly people than ever before.

Business models will need to (be allowed to) evolve to include alternative paths to prevention or anticipation of disease.

This presents new opportunities for parties including governments, health care providers and pharmaceutical companies to innovate and collaborate — and there is significant potential to improve the quality of life for elderly people, and drive cost-efficiency for governments and reimbursement for providers.

Read the full article to discover more.

The article was written by:

  • Patrick Flochel
    Partner, Advisory Services — Life Sciences, Ernst & Young Advisory Co. Ltd, Japan
  • Frank Kumli, PhD
    Executive Director, Advisory Services — Life Sciences, Ernst & Young AG, Switzerland
  • Stephan Ohnmacht, PhD
    Manager, Advisory Services — Life Sciences, Ernst & Young AG, Switzerland
  • Christoph Wellinger
    Partner, Advisory Services — Life Sciences, Ernst & Young AG, Switzerland
EY refers to one or more of the member firms of Ernst & Young Global Limited (EYG), a UK private company limited by guarantee. EYG is the principal governance entity of the global EY organization and does not provide any service to clients. Services are provided by EYG member firms. Each of EYG and its member firms is a separate legal entity and has no liability for another such entity's acts or omissions. Certain content on this site may have been prepared by one or more EYG member firms